We navigate you through the healthcare market.

Consultancy for medical device companies to support Market Access of innovative medical products.

Market Access

What is needed for a successful Market Access in Germany?

Reimbursement

How are therapies in the healthcare system reimbursed?

Economics

Hospital economics vs. Health economics?

Evidence

What kind of evidence is needed for your goals?

External Affairs

Who are the relevant stakeholders in the healthcare system?

Who we are

Healthcare Heads specializes in delivering tailored consultancy services in Reimbursement and Market Access exclusively designed for medical companies targeting the German healthcare market.

Our mastery of Market Access spans across pivotal areas encompassing Reimbursement, Economics, Evidence and External Affairs. These key focal points empower us to provide you with holistic and all-encompassing solutions.

Distinguished by an unparalleled fusion of expertise and an extensive track record within the German healthcare realm, we stand as your foremost partner in shaping Reimbursement and Market Access strategies and ensuring their seamless operational integration.

In collaboration with you, we surmount barriers that impede market entry, unlocking pathways to connect your pioneering technology with a broader spectrum of patients. Let us embark on this journey together, unraveling the full potential of your innovation.

E-Mail: info@healthcareheads.com

Phone: +49 431 800 147 0

The proceedings for the development of the aG-DRG system for 2027 have started. Experts from medicine, science, and other fields can now submit proposals to InEK.

The InEK (Institute for the Hospital Reimbursement System) published the DRG catalog 2026 including the new pre-reimbursement.

On November 20, 2025, the self-governing partners at federal level adopted the new DRG and care tariff catalog for 2026.

The new Hybrid-DRG catalog for 2026 has been approved – bringing significant changes to both inpatient and outpatient care. The number of hybrid flat rates will increase from 22 to 69 Hybrid-DRGs.

According to the GKV-Spitzenverband, the German expanded evaluation committee has passed the new Hybrid-DRG catalog.

FAQ series: Hybrid-DRGs

Cross-sector reimbursement opens up new possibilities - but also brings complex challenges.

Take advantage of our expertise.

On the 24th of October, 2025, the BfArM published the final version of the OPS Version 2026.

FAQ series: Hybrid DRGs

Subscribe to the Healthcare Heads newsletter

with topics of Market Access and Reimbursement in Germany.

Don't miss any of the latest developments and be among the first to receive relevant information from the areas of market access and reimbursement in Germany.

Salutation

Your Name

Homepage

E-mail*

Privacy policy

I have taken note of the data protection notice

Marketing von